2022
DOI: 10.1016/j.gie.2022.07.018
|View full text |Cite
|
Sign up to set email alerts
|

EUS-guided gastroenterostomy versus duodenal self-expandable metal stent for malignant gastric outlet obstruction: results from a nationwide multicenter retrospective study (with video)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 30 publications
1
15
0
Order By: Relevance
“…We also excluded those that did not specify the techniques used or if there were mixed EUS-GE techniques in the pool of patients. A total of 20 studies fulfilled our inclusion criteria: 12 case series and eight comparative studies [12,14,[23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…We also excluded those that did not specify the techniques used or if there were mixed EUS-GE techniques in the pool of patients. A total of 20 studies fulfilled our inclusion criteria: 12 case series and eight comparative studies [12,14,[23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40].…”
Section: Resultsmentioning
confidence: 99%
“…All studies reported clinical success [12,14,[23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40]. Clinical success rates were 90.6% for DGE and 88.9% for BTGE (Table 6) with an RD of -0.007 (95% CI -0.06 to 0.046 I2=0% p=0.798) without statistical difference between the groups (Figure 3).…”
Section: Clinical Successmentioning
confidence: 96%
See 2 more Smart Citations
“…Notably, the median elapsed time between the symptoms and the EUS-GE was short in both groups (4 and 6 days). A recent multicenter retrospective study including 97 patients comparing EUS-GE and ES concluded that EUS-GE seems to have improved patency outcomes for palliative treatment of malignant GOO [ 23 ]. In our series, although the baseline GOOSS was also comparable, the GOOSS improvement at 48 h was higher in patients with a duodenal stent.…”
Section: Discussionmentioning
confidence: 99%